Vésale Enters Chinese Probiotics Market

NOVILLE, BelgiumVésale Pharma has partnered with Hainan Honz Pharmaceutical Co. Ltd. to distribute its patented probiotic Intelicaps® in China. With headquarters in Guangzhou, Hainan Honz is one of China's leading pediatric drugs company. The agreement covers Vésale's children's probiotics products.

"Our distribution agreement with Vésale Pharma draws on the strengths of both our companies, creating a strong, strategic partnership for the development, registration, distribution and sales of Vésale's probiotic portfolio," said Bin Xiao, Honz marketing director. "The localization of Intelicaps® probiotic line for the Chinese market is the first time Honz has brought in leading edge international probiotic technologies and products to enhance our children's health product lineup."

Vésale is also expanding into the Middle East. The company currently has market authorizations for the United Arab Emirates and Kuwait.

Interested in entering the Chinese marketplace? Read INSIDER's exclusive Q&A, "Practical Advice for Doing Business in China."